The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Influenza Drugs-Global Market Insights and Sales Trends 2024
Synopsis
The global Influenza Drugs market size is expected to reach US$ 2151.5 million by 2029, growing at a CAGR of 3.3% from 2023 to 2029. The market is mainly driven by the significant applications of Influenza Drugs in various end use industries. The expanding demands from the Adults and Chidren, are propelling Influenza Drugs market. Zanamivir, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Oseltamivir Phosphate segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Influenza Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Influenza Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Influenza Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Influenza Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Influenza Drugs covered in this report include Bristol-Myers Squibb], AstraZeneca, Eli Lilly, Roche, GlaxoSmithKline, Novartis, Pfizer, Sanofi Pasteur and Bayer, etc.
The global Influenza Drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bristol-Myers Squibb]
AstraZeneca
Eli Lilly
Roche
GlaxoSmithKline
Novartis
Pfizer
Sanofi Pasteur
Bayer
Celgene
Seqirus
Protein Sciences Corporation
Serum Institute of India
Emergent Biosolutions
BioCryst Pharmaceuticals
Alvogen
Global Influenza Drugs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Influenza Drugs market, Segment by Type:
Zanamivir
Oseltamivir Phosphate
Peramivir
Other Influenza Drugs
Global Influenza Drugs market, by Application
Adults
Chidren
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Influenza Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Influenza Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
The global Influenza Drugs market size is expected to reach US$ 2151.5 million by 2029, growing at a CAGR of 3.3% from 2023 to 2029. The market is mainly driven by the significant applications of Influenza Drugs in various end use industries. The expanding demands from the Adults and Chidren, are propelling Influenza Drugs market. Zanamivir, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Oseltamivir Phosphate segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Influenza Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Influenza Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Influenza Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Influenza Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Influenza Drugs covered in this report include Bristol-Myers Squibb], AstraZeneca, Eli Lilly, Roche, GlaxoSmithKline, Novartis, Pfizer, Sanofi Pasteur and Bayer, etc.
The global Influenza Drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bristol-Myers Squibb]
AstraZeneca
Eli Lilly
Roche
GlaxoSmithKline
Novartis
Pfizer
Sanofi Pasteur
Bayer
Celgene
Seqirus
Protein Sciences Corporation
Serum Institute of India
Emergent Biosolutions
BioCryst Pharmaceuticals
Alvogen
Global Influenza Drugs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Influenza Drugs market, Segment by Type:
Zanamivir
Oseltamivir Phosphate
Peramivir
Other Influenza Drugs
Global Influenza Drugs market, by Application
Adults
Chidren
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Influenza Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Influenza Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Influenza Drugs Market Overview
1.1 Influenza Drugs Product Overview
1.2 Influenza Drugs Market Segment by Type
1.2.1 Zanamivir
1.2.2 Oseltamivir Phosphate
1.2.3 Peramivir
1.2.4 Other Influenza Drugs
1.3 Global Influenza Drugs Market Size by Type
1.3.1 Global Influenza Drugs Market Size Overview by Type (2018-2029)
1.3.2 Global Influenza Drugs Historic Market Size Review by Type (2018-2023)
1.3.3 Global Influenza Drugs Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Influenza Drugs Sales Breakdown by Type (2018-2023)
1.4.2 Europe Influenza Drugs Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Influenza Drugs Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Influenza Drugs Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Influenza Drugs Sales Breakdown by Type (2018-2023)
2 Global Influenza Drugs Market Competition by Company
2.1 Global Top Players by Influenza Drugs Sales (2018-2023)
2.2 Global Top Players by Influenza Drugs Revenue (2018-2023)
2.3 Global Top Players by Influenza Drugs Price (2018-2023)
2.4 Global Top Manufacturers Influenza Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Influenza Drugs Market Competitive Situation and Trends
2.5.1 Influenza Drugs Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Influenza Drugs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Influenza Drugs as of 2022)
2.7 Date of Key Manufacturers Enter into Influenza Drugs Market
2.8 Key Manufacturers Influenza Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Influenza Drugs Status and Outlook by Region
3.1 Global Influenza Drugs Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Influenza Drugs Historic Market Size by Region
3.2.1 Global Influenza Drugs Sales in Volume by Region (2018-2023)
3.2.2 Global Influenza Drugs Sales in Value by Region (2018-2023)
3.2.3 Global Influenza Drugs Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Influenza Drugs Forecasted Market Size by Region
3.3.1 Global Influenza Drugs Sales in Volume by Region (2024-2029)
3.3.2 Global Influenza Drugs Sales in Value by Region (2024-2029)
3.3.3 Global Influenza Drugs Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Influenza Drugs by Application
4.1 Influenza Drugs Market Segment by Application
4.1.1 Adults
4.1.2 Chidren
4.2 Global Influenza Drugs Market Size by Application
4.2.1 Global Influenza Drugs Market Size Overview by Application (2018-2029)
4.2.2 Global Influenza Drugs Historic Market Size Review by Application (2018-2023)
4.2.3 Global Influenza Drugs Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Influenza Drugs Sales Breakdown by Application (2018-2023)
4.3.2 Europe Influenza Drugs Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Influenza Drugs Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Influenza Drugs Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Influenza Drugs Sales Breakdown by Application (2018-2023)
5 North America Influenza Drugs by Country
5.1 North America Influenza Drugs Historic Market Size by Country
5.1.1 North America Influenza Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Influenza Drugs Sales in Volume by Country (2018-2023)
5.1.3 North America Influenza Drugs Sales in Value by Country (2018-2023)
5.2 North America Influenza Drugs Forecasted Market Size by Country
5.2.1 North America Influenza Drugs Sales in Volume by Country (2024-2029)
5.2.2 North America Influenza Drugs Sales in Value by Country (2024-2029)
6 Europe Influenza Drugs by Country
6.1 Europe Influenza Drugs Historic Market Size by Country
6.1.1 Europe Influenza Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Influenza Drugs Sales in Volume by Country (2018-2023)
6.1.3 Europe Influenza Drugs Sales in Value by Country (2018-2023)
6.2 Europe Influenza Drugs Forecasted Market Size by Country
6.2.1 Europe Influenza Drugs Sales in Volume by Country (2024-2029)
6.2.2 Europe Influenza Drugs Sales in Value by Country (2024-2029)
7 Asia-Pacific Influenza Drugs by Region
7.1 Asia-Pacific Influenza Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Influenza Drugs Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Influenza Drugs Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Influenza Drugs Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Influenza Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Influenza Drugs Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Influenza Drugs Sales in Value by Region (2024-2029)
8 Latin America Influenza Drugs by Country
8.1 Latin America Influenza Drugs Historic Market Size by Country
8.1.1 Latin America Influenza Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Influenza Drugs Sales in Volume by Country (2018-2023)
8.1.3 Latin America Influenza Drugs Sales in Value by Country (2018-2023)
8.2 Latin America Influenza Drugs Forecasted Market Size by Country
8.2.1 Latin America Influenza Drugs Sales in Volume by Country (2024-2029)
8.2.2 Latin America Influenza Drugs Sales in Value by Country (2024-2029)
9 Middle East and Africa Influenza Drugs by Country
9.1 Middle East and Africa Influenza Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Influenza Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Influenza Drugs Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Influenza Drugs Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Influenza Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Influenza Drugs Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Influenza Drugs Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Bristol-Myers Squibb]
10.1.1 Bristol-Myers Squibb] Company Information
10.1.2 Bristol-Myers Squibb] Introduction and Business Overview
10.1.3 Bristol-Myers Squibb] Influenza Drugs Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Bristol-Myers Squibb] Influenza Drugs Products Offered
10.1.5 Bristol-Myers Squibb] Recent Development
10.2 AstraZeneca
10.2.1 AstraZeneca Company Information
10.2.2 AstraZeneca Introduction and Business Overview
10.2.3 AstraZeneca Influenza Drugs Sales, Revenue and Gross Margin (2018-2023)
10.2.4 AstraZeneca Influenza Drugs Products Offered
10.2.5 AstraZeneca Recent Development
10.3 Eli Lilly
10.3.1 Eli Lilly Company Information
10.3.2 Eli Lilly Introduction and Business Overview
10.3.3 Eli Lilly Influenza Drugs Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Eli Lilly Influenza Drugs Products Offered
10.3.5 Eli Lilly Recent Development
10.4 Roche
10.4.1 Roche Company Information
10.4.2 Roche Introduction and Business Overview
10.4.3 Roche Influenza Drugs Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Roche Influenza Drugs Products Offered
10.4.5 Roche Recent Development
10.5 GlaxoSmithKline
10.5.1 GlaxoSmithKline Company Information
10.5.2 GlaxoSmithKline Introduction and Business Overview
10.5.3 GlaxoSmithKline Influenza Drugs Sales, Revenue and Gross Margin (2018-2023)
10.5.4 GlaxoSmithKline Influenza Drugs Products Offered
10.5.5 GlaxoSmithKline Recent Development
10.6 Novartis
10.6.1 Novartis Company Information
10.6.2 Novartis Introduction and Business Overview
10.6.3 Novartis Influenza Drugs Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Novartis Influenza Drugs Products Offered
10.6.5 Novartis Recent Development
10.7 Pfizer
10.7.1 Pfizer Company Information
10.7.2 Pfizer Introduction and Business Overview
10.7.3 Pfizer Influenza Drugs Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Pfizer Influenza Drugs Products Offered
10.7.5 Pfizer Recent Development
10.8 Sanofi Pasteur
10.8.1 Sanofi Pasteur Company Information
10.8.2 Sanofi Pasteur Introduction and Business Overview
10.8.3 Sanofi Pasteur Influenza Drugs Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Sanofi Pasteur Influenza Drugs Products Offered
10.8.5 Sanofi Pasteur Recent Development
10.9 Bayer
10.9.1 Bayer Company Information
10.9.2 Bayer Introduction and Business Overview
10.9.3 Bayer Influenza Drugs Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Bayer Influenza Drugs Products Offered
10.9.5 Bayer Recent Development
10.10 Celgene
10.10.1 Celgene Company Information
10.10.2 Celgene Introduction and Business Overview
10.10.3 Celgene Influenza Drugs Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Celgene Influenza Drugs Products Offered
10.10.5 Celgene Recent Development
10.11 Seqirus
10.11.1 Seqirus Company Information
10.11.2 Seqirus Introduction and Business Overview
10.11.3 Seqirus Influenza Drugs Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Seqirus Influenza Drugs Products Offered
10.11.5 Seqirus Recent Development
10.12 Protein Sciences Corporation
10.12.1 Protein Sciences Corporation Company Information
10.12.2 Protein Sciences Corporation Introduction and Business Overview
10.12.3 Protein Sciences Corporation Influenza Drugs Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Protein Sciences Corporation Influenza Drugs Products Offered
10.12.5 Protein Sciences Corporation Recent Development
10.13 Serum Institute of India
10.13.1 Serum Institute of India Company Information
10.13.2 Serum Institute of India Introduction and Business Overview
10.13.3 Serum Institute of India Influenza Drugs Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Serum Institute of India Influenza Drugs Products Offered
10.13.5 Serum Institute of India Recent Development
10.14 Emergent Biosolutions
10.14.1 Emergent Biosolutions Company Information
10.14.2 Emergent Biosolutions Introduction and Business Overview
10.14.3 Emergent Biosolutions Influenza Drugs Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Emergent Biosolutions Influenza Drugs Products Offered
10.14.5 Emergent Biosolutions Recent Development
10.15 BioCryst Pharmaceuticals
10.15.1 BioCryst Pharmaceuticals Company Information
10.15.2 BioCryst Pharmaceuticals Introduction and Business Overview
10.15.3 BioCryst Pharmaceuticals Influenza Drugs Sales, Revenue and Gross Margin (2018-2023)
10.15.4 BioCryst Pharmaceuticals Influenza Drugs Products Offered
10.15.5 BioCryst Pharmaceuticals Recent Development
10.16 Alvogen
10.16.1 Alvogen Company Information
10.16.2 Alvogen Introduction and Business Overview
10.16.3 Alvogen Influenza Drugs Sales, Revenue and Gross Margin (2018-2023)
10.16.4 Alvogen Influenza Drugs Products Offered
10.16.5 Alvogen Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Influenza Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Influenza Drugs Industrial Chain Analysis
11.4 Influenza Drugs Market Dynamics
11.4.1 Influenza Drugs Industry Trends
11.4.2 Influenza Drugs Market Drivers
11.4.3 Influenza Drugs Market Challenges
11.4.4 Influenza Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Influenza Drugs Distributors
12.3 Influenza Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
